FAP and neoplasm: Findings, mainly derived from preclinical studies, suggest that the inhibition of FAP-enzymatic activity induced by low molecular weight inhibitors has the potential to decrease the invasiveness of malignant cells and further lead to a considerable reduction of the tumor growth [94].